
European Journal of Medicinal Chemistry p. 957 - 967 (1998)
Update date:2022-08-04
Topics:
Caliendo, Giuseppe
Grieco, Paolo
Perissutti, Elisa
Santagada, Vincenzo
Santini, Antonello
Albrizio, Stefania
Fattorusso, Caterina
Pinto, Aldo
Sorrentino, Raffaella
With the aim of discovering new molecules with K+-channel activating properties, we have synthesized derivatives of cromakalim (CRK), an important molecule which shows specific affinity towards K+ channels, by replacing the benzopyrane ring of this reference compound with a 1,4-benzoxazine moiety. A different number of substituents showing a good discrimination between hydrophobic and electronic properties have been inserted at the 6-position of the 1,4-benzoxazine ring. We describe here the synthesis and discuss the solid state conformation of these new molecules. When tested on rat aorta ring precontracted with phenylephrine, two compounds (2c and 2d) showed a concentration-dependent relaxation similar to that measured for cromakalim but less potent than this reference drug.
View MoreXI'AN CHUKANG BIOTECHNOLOGY CO.,LTD
Contact:29-63685658 63685359
Address:Room 3-1202,Building 1,Oriental oasis,East of Xianning Road,Xi'an,Shaanxi 710043 P.R.China
Contact:+44 (0)161 367 9441
Address:
zhenjiang runjing high purity chemical co ltd
Contact:+86-511-83361155
Address:No.8.haixi road,international chemical park
JIANGSU GRAND XINYI PHARMACEUTICAL CO.,LTD
website:http://www.xypharm.com/
Contact:+86-515-84383317
Address:Chenli Road,Costal Chemical Area Binhai,Yancheng, Jiangsu,China
Changde Yungang Biotechnology Co., Ltd
website:http://www.cdyg.com
Contact:+86-736-7391178
Address:Qiaonan Industrial Park, Changde City, Hunan Province
Doi:10.1021/jo00838a036
(1969)Doi:10.1071/CH9951873
(1995)Doi:10.1016/0040-4039(95)01518-3
(1995)Doi:10.1021/om950574q
(1996)Doi:10.1021/ja00151a030
(1995)Doi:10.1055/s-2006-942359
(2006)